The emerging literature studying the association between exposure to ambient air pollution and Parkinson's Disease (PD) so far draws mixed conclusions. This study provides new evidence on this issue using data from a large and nationally representative cohort tracked over an extended period. We...

Purpose - Health shocks are among the factors that have impeded households from experiencing better welfare. To mitigate the consequences of these shocks, individuals have sought to enrol in a formal insurance scheme or borrow from banks. This study estimates the effects of health shocks on...

Background In their interesting systematic review, Gallehzan et al. quoted our article Cost-utility analysis of teriflunomide in naïve vs. previously treated patients with relapsing-remitting multiple sclerosis (RRMS) in Italy. While we are grateful to Gallehzan et al. for their interest in the...

We analyze administrative and genetic data from over 200,000 Danes to study the effects of genetic risk for Alzheimer's Disease (AD) on labor market outcomes. Higher AD genetic risk increases dementia diagnoses and GP visits for both genders. Among women aged 45–65, it reduces labor...

We analyze the effect of adverse health shocks on households' expenditure shares in different good categories using a fixed-effects approach and a structural approach based on microeconomic theory. We find that, on average, households substitute health and food expenditure in response to adverse...

We analyze the impact of unexpected health shocks - defined as the sudden diagnosis of cancer, stroke, or heart attack - on the probability of couple dissolution using longitudinal representative data on older individuals (50+). We leverage the longitudinal nature of the HRS and utilize a...

This study investigates lifetime socioeconomic health disparities through longitudinal biomarkers from the Dutch Lifelines cohort study and biobank. We construct an allostatic load index from 12 biomarkers and analyze the dynamics of health and its association with socioeconomic status (SES)...

We analyze the impact of unexpected health shocks—defined as the sudden diagnosis of cancer, stroke, or heart attack—on the probability of couple dissolution using longitudinal representative data on older individuals (50+). We leverage the longitudinal nature of the HRS and utilize a...

Illness, or the medical treatment of a family member, comprises an inherent part of human life, the occurrence of which often prevents employees from attending work. This article analyses the relationship between absence from work due to illness and the amount of an individual's income. The...

We examine the effect of fatal and nonfatal health shocks on household debt defaults. Fatal shocks significantly cause defaults, especially among surviving spouses lacking sufficient resources, namely housing wealth. Our findings suggest that this behavior is not due to inattention. These shocks...

This report provides information about the environmental determinants of chronic respiratory disease (CRD) to support EU policy responses. It is based on data compiled by the EEA and supports the European Green Deal, as well as EU action against pollution, climate change, occupational risks and...

This briefing quantifies the latest estimated impact on population health caused by long-term exposure to three key air pollutants: fine particulate matter, nitrogen dioxide and ozone. The foreseen benefits of achieving improved air quality are also highlighted.

This core protocol for ECDC studies of VE against hospitalisation with severe acute respiratory infection (SARI) laboratory-confirmed with SARS-CoV-2 or with influenza, version 4.0, represents an update to the main elements for a multi-country hospital-based study of COVID-19 vaccine...

There are around 36 million patients suffering from rare diseases in the EU. This in-depth analysis gives an overview of European actions for rare diseases to date and identifies opportunities and gaps for further EU level actions to improve diagnosis, care, and treatment for rare diseases. This...

There are around 36 million patients suffering from rare diseases in the EU. This in-depth analysis gives an overview of European actions for rare diseases to date and identifies opportunities and gaps for further EU level actions to improve diagnosis, care, and treatment for rare diseases. This...

This document outlines the objectives and main elements of the ECDC framework for prevention of communicable diseases and related special health issues. It sets out a vision for strong, effective and evidence-based prevention of communicable disease in the European Union/European Economic Area...

Cancer and other non-communicable diseases (NCDs) represent a significant portion of the disease burden in Europe, much of which is preventable. Joint Action PreventNCD aims to reduce Europe's cancer and NCD burden through coordinated strategies on health determinants, focusing on effective...

The end of 2019 saw the emergence of a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19). As of October 2023, almost 276 million cases and more than 2.2 million deaths had been reported in the WHO European Region [1]. As of October...

This study addresses the gender gap in workplace sick leave duration, focusing on the underlying economic and biological factors that contribute to this disparity. Using a novel methodological approach, we combine the stochastic frontier technique with an Oaxaca-Blinder-type decomposition to...

We estimate the role of firms in worker health care utilization. Using linked administrative data on Austrian workers from 1998-2018, we exploit mobility between firms to estimate how much a firm contributes to worker-level differences in utilization in a setting with non-employer provided...

f Sickness insurance guarantees employees the right to take leave from work when they are sick, but is vulnerable to excessive use because monitoring of recipients' health is difficult and costly. In terms of costs, it would be preferable to focus monitoring on individuals whose sickness absence...

The COVID-19 (coronavirus disease of 2019) pandemic is over; however, the probability of such a pandemic is about 2% in any year. There are international negotiations among almost 200 countries at the World Health Organization (WHO) concerning a global plan to deal with the next pandemic on the...

Background The costs associated with respiratory illnesses in the French healthcare budget continue to rise. How- ever, pharmaceutical companies and research centres are continuously developing new treatments. Consequently, accepting these treatments, which necessitates the acceptance of the...

Background There is sparse evidence on the joint effects of ill-health, health shocks and social protection on the intensive margin of labour supply, particularly in developing countries. We interact ill-health and health shocks with access to social protection and estimate their joint effects...